Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 11 symbols : Abbv save search
AbbVie, Richter Unite to Target Complex Neuropsychiatric Conditions
Published: 2022-03-11 (Crawled : 15:00) - biospace.com/
ABBV | $163.42 1.08% 2M
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
neuropsychiatric
Therapeutics for Women's Health - A Comprehensive Industry Assessment Highlighting the Key Opportunities, Pricing & Reimbursement, Players, and Strategic Recommendations - Forecast to 2026
Published: 2022-03-11 (Crawled : 13:30) - prnewswire.com
SNYNF | $92.966 630
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: 0.0%
AZNCF | $135.94 770
|
Health Technology
|
| O: -2.32%
H: 2.3%
C: 0.22%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: 0.63%
H: 0.0%
C: 0.0%
JNJ | $145.405 -1.48% 7.6M
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
ABBV | $163.42 1.08% 2M
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 1.22%
H: 0.0%
C: 0.0%
AZN | $68.38 -0.51% 2.1M
|
Health Technology
|
| O: 0.98%
H: 0.0%
C: 0.0%
AMGN | $264.955 -0.21% 880K
|
Health Technology
|
| O: -0.66%
H: 0.0%
C: 0.0%
health therapeutics women
AbbVie and Gedeon Richter Announce Collaboration in Neuropsychiatric Diseases
Published: 2022-03-11 (Crawled : 08:00) - prnewswire.com
ABBV | $163.42 1.08% 2M
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
disease collaboration neuropsychiatric
Gainers vs Losers
| 54% | 46% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
JAGX | $0.1771 49.07% 540M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
MCBC | $13.74 38.37% 1.6M
|
Finance
PALI | $5.51 32.45% 28M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.